Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> H >> rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide

rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
[CAS# 1127442-82-3]

List of Suppliers
Taizhou Crene Biotechnology Co., Ltd. China Inquire  
+86 (576) 8881-3233
8820-5808
+86 13396860566
order@pharm-intermediates.com
QQ chat
Chemical manufacturer since 2011
chemBlink standard supplier since 2009
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Amadis Chemical Co., Ltd. China Inquire  
+86 (571) 8992-5085
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink standard supplier since 2015
Santa Cruz Biotechnology, Inc. USA Inquire  
+1 (831) 457-3800
scbt@scbt.com
Chemical manufacturer
Complete supplier list of rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
Identification
Classification Biochemical >> Inhibitor >> Stem cells & wnt signaling paths (Stem cells & wnt) >> Wnt/beta-catenin inhibitor
Name rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
Molecular Structure CAS # 1127442-82-3, rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
Molecular Formula C25H19N3O3
Molecular Weight 409.44
CAS Registry Number 1127442-82-3
Properties
Solubility Insoluble (5.3E-6 g/L) (25 ºC), Calc.*
Density 1.425±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs)
Safety Data
SDS Available
Market Analysis Reports
List of Reports Available for rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide
Related Products
(2Z)-4-[(1R,3aS,5S,6S,6aR,11S,14aS)-3a,4,5,6,6a,7-Hexahydro-6,8-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenoic acid  [2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol  1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one  (5aR,6aR,7aS)-Hexahydro-3,3-dimethyl-3H,5H-cycloprop[d]oxazolo[3,4-a]pyridin-5-one  1,2,5,6,7,8-Hexahydro-7,7-dimethyl-2-oxo-3-quinolinecarboxylic acid  Hexahydro-2'3a-dimethylspiro[1,3-dithiolo[4,5-b]furan-2,3'(2'H)-furan]  (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl 2,2-dimethyl-3-butenoate  6,7,8,9,10,10a-Hexahydro-N,N-dimethyl-2-(trifluoromethyl)benzo[b]cyclohepta[e][1,4]thiazine-11(5aH)-propanamine monohydrochloride dihydrate  2,3,6a,7,8,9-Hexahydro-11H-1,4-dioxino[2,3-g]pyrrolo[2,1-b][1,3]benzoxazin-11-one  4-(1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)-N-8-quinolinylbenzamide  [3S-[2(R*),3alpha,8abeta]]-[2-[Hexahydro-1,4-dioxo-3-(phenylmethyl)pyrrolo[1,2-a]pyrazin-2(1H)-yl]-1-methyl-2-oxoethyl]carbamic acid phenylmethyl ester  (S)-Hexahydro-2,6-dioxo-4-pyrimidinecarboxylic acid phenylmethyl ester  1,2,5,6,7,8-Hexahydro-2,5-dioxo-3-quinolinecarboxylic acid methyl ester  Hexahydro-5,8-dioxo-3H-thiazolo[3,4-a]pyrazine-6-propanoic acid  [2R-(2alpha,4abeta,5aalpha,8alpha,9aalpha,9bbeta)]-Hexahydro-2,8-diphenyl-4H-bis[1,3]dioxino[5,4-b:4',5'-d]pyrrole  Hexahydro-4,8-ethano-1H,3H-benzo[1,2-c:4,5-c']difuran-1,3,5,7-tetrone  (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol  rel-(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl 4-nitrophenyl carbonic acid ester  Hexahydro-1H-furo[3,4-c]pyrrole hydrochloride  2,2,4,4,6,6-Hexahydro-2,2,4,4,6,6-hexakis[(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluorooctyl)oxy]-1,3,5,2,4,6-triazatriphosphorine